E.g., 12/17/2018
E.g., 12/17/2018
Title Category Credit Event date Price
Male Sexual Dysfunction for APPs (2017)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$40.00 Member only benefit! In this era of increasing responsibility for primary care physicians and primary mid-level providers, it is important to recognize male sexual dysfunction may be mitigated due to advance lifestyle changes and risk factors need to be addressed and altered. Many APN/PAs also do not know what tests are appropriate for the work-up of male sexual dysfunction. Basic knowledge and understanding of male sexual dysfunction and its reflection of underlying health issues for the patient is needed.
Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging & Treatment Webcast 058IC (2018)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether biopsy or rebiopsy is warranted? 4. Whats the optimal biopsy strategy: Transrectal, transperineal, MRI-cognitive, MRI fusion? 5. Discuss Active Surveillance, Rad Px, XRT and focal therapy pros and cons for PSA-detected cancer. 6. What is role of adjuvant v. salvage XRT post-RP? 7. Review new PET scans for biochemically recurrent disease after RP or XRT. 8.
Management of Prostate Cancer: A Case-Based Approach with Emphasis on Integrating New Molecular Diagnostics into Clinical Practice Webcast 078IC (...
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice.
Masterclass Webinar: Testosterone Deficiency (Espanol) (2018) $0.00 AUA is pleased to bring this FREE 60-minute, non-cme online educational series, presented in Spanish to the global urologic community.  Dr. Alejandro Rodriguez is joined by expert faculties Drs. Rafael Carrion, Adrian Momesso and Miguel Rivero for an exciting program featuring didactic lectures from AUA2018 Second Opinion Cases on Testosterone Defiency. Specific topics include:
Multi-parametric Ultrasound in the Diagnosis of Prostate Cancer Webcast (2017)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 Member only benefit! Transrectal ultrasound is critical to biopsy guidance for the diagnosis of prostate cancer. However, ultrasound has the ability to improve diagnostic accuracy and may perform as well as multi-parametric MRI in identifying suspicious lesions. This course will familiarize participants with gray-scale ultrasound, color and power Doppler ultrasound, elastography and contrast-enhanced ultrasound as modalities which alone or in combination may improve the diagnosis of prostate cancer. 
New Muscle Invasive Bladder Cancer Guideline Webcast (2017)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.
Next Frontiers in Urology: a Biennial AUA/JUA Symposium: Advancements in Urology (2019)
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Non-Physician Participation
02/06/2019 $845.00 Join the AUA, the JUA and some of today’s global leaders in urologic medicine for an in-depth look at the latest advances in urology!This biennial symposium gathers esteemed faculty and leadership from both the American Urological Association (AUA) and the Japanese Urological Association (JUA).  Join us to network with your colleagues and get the latest updates in clinical guidelines and new and emerging treatment options in urologic medicine. 
Novel Agents & Concepts in the Management of Hormone-Naïve & Castrate-Resistant Prostate Cancer Webcast 043IC (2018)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for advanced prostate cancer-both non-metastatic and metastatic CRPC. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed.
Oral Board Review Course (2019) 01/25/2019 $2,025.00 A Few Spots Still Remain for Friday Course- Register NOW!Satuday Course is SOLD OUT
Oral Board Study Guide App (iOS and Android) $299.00 The AUA Oral Board Study Guide App features 68 interactive protocols in 34 topic areas. Developed by leading experts in urology, the app has been specifically designed for urologists preparing to take this examination and includes a strong emphasis on AUA Guidelines with direct access to the AUA Guidelines and the AUA Urology Core Curriculum for AUA members. Available for use on Apple and Android devices!
Patient Safety Course (2018)
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Non-Physician Participation
$0.00 The Patient Safety Course is designed to provide urologists and the urology care team with the knowledge required to apply appropriate patient safety procedures in a urologic practice.  Urology specific examples will help learners understand patient safety concepts, how safety issues arise, and how they can be mitigated.
Practical Management of Metastatic Prostate Cancer: Guidelines and Beyond Webcast (2017)
  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Non-Physician Participation
$0.00 Urologists continue to indicate one of the greatest educational needs in treating CRPC patients is the sequencing of agents. With the numerous new treatments now available to urologists to manage the CRPC patient, sequencing and managing the side effects of each treatment have become increasingly important. In addition, studies are demonstrating that earlier treatment with these systemic agents has improved efficacy.
Practical PCNL: From Access to Exit- A Hands-on Course- California (2019)
  • 12.25 AMA PRA Category 1 Credit™
  • 12.25 Non-Physician Participation
02/23/2019 $1,950.00 Don't miss the only cadaver based hands-on PCNL course of 2019!Directed by Ralph V. Clayman, MD and Jaime Landman, MD, this newly enhanced course will feature a combination of didactic lectures, surgical video cases, panel discussions, Q & A sessions, an interactive review using audience response and hands-on surgical skill stations that allow each participant to perform percutaneous stone removal from start to finish on human cadavers for more accurate training.
Practical Uroradiology: The Office Based Interpretation of Urologic Radiographic Studies Webcast (2017)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 Member only benefit! Course is designed with the busy clinician and mid-level providers in mind as a review and update on recent advances in urologic imaging including: CT, MRI, Renal scan, PET scan for gurlogical malignancy, and prostate imaging. Interpretation of normal contrasted with abnormal MRI and CT will be the foundation for discussing conditions commonly seen and treated by the urologist reviewing films in the office.
Practice Management Conference - Virtual Meeting (2018) $349.00 Due to continuous legislative, regulatory and coding changes practice managers and urologists lack the knowledge required to implement changes to their practice.

Pages